Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ITACONIX PLC Director's Dealing 2019

Aug 5, 2019

7720_dirs_2019-08-05_1e9b0344-5f9b-4040-9d03-107d68d8d5a3.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8212H

Itaconix PLC

05 August 2019

5 August 2019                                                                                                   

Itaconix plc ("Itaconix" or "the Company")

PDMR Shareholding

Itaconix, a leading innovator in sustainable specialty polymers, announces that it has been notified that certain of the Directors and PDMRs of the Company purchased ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares"). Details of the respective purchases, together with total resultant shareholdings, are as follows:

PDMR Number of shares purchased Resulting total interest in Ordinary Shares % of total issued share capital
James Barber

Chairman
721,818 1,466,818 0.5%
John R. Shaw

Chief Executive Officer
721,818 33,894,915 12.6%
John I. Snow III

Non-Executive Director
1,849,568 1,849,568 0.7%
Laura Denner

Group Director, Finance & Operations
5,548,886 6,696,535 2.5%
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name James Barber
2 Reason for the notification
a) Position/status Chairman, PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Itaconix plc
b) LEI 213800OKA3GOCK2ZA496
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code GB00B84LVH87
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
1.1 pence 721,818
d) Aggregated information
- Aggregated volume n/a
- Price
e) Date of the transaction 02 August 2019
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name John R. Shaw
2 Reason for the notification
a) Position/status Chief Executive Officer, PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Itaconix plc
b) LEI 213800OKA3GOCK2ZA496
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code GB00B84LVH87
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
1.1 pence 721,818
d) Aggregated information
- Aggregated volume n/a
- Price
e) Date of the transaction 02 August 2019
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name John I. Snow III
2 Reason for the notification
a) Position/status Non-Executive Director, PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Itaconix plc
b) LEI 213800OKA3GOCK2ZA496
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code GB00B84LVH87
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
1.1 pence 1,849,568
d) Aggregated information
- Aggregated volume n/a
- Price
e) Date of the transaction 02 August 2019
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Laura Denner
2 Reason for the notification
a) Position/status Group Director, Finance & Operations, PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Itaconix plc
b) LEI 213800OKA3GOCK2ZA496
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code GB00B84LVH87
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
1.1 pence 5,548,886
d) Aggregated information
- Aggregated volume n/a
- Price
e) Date of the transaction 02 August 2019
f) Place of the transaction London Stock Exchange

Ends

For further information please contact:

Itaconix plc +1 603 775-4400
John R. Shaw
N+1 Singer +44 (0) 207 496 3000
Richard Lindley / James Moat (Corporate Finance)

About Itaconix

Itaconix develops and produces bio-based specialty polymers that improve the safety, performance or sustainability of consumer and industrial products, with technology and market leadership positions in non-phosphate detergents, odour control, and hair styling.  

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHEANPLEAANEFF